Business Wire

mimik Operationalizes Agentic AI on the AMD Ryzen™ AI Embedded X100 Series

23.7.2026 20:30:00 CEST | Business Wire | Press Release

Share

mimik today announced mimOE™ Embedded Edition, a package of its Agentix Operating Engine and a set of purpose-built tools for the AMD Ryzen™ AI Embedded X100 Series processor, the newest processor in a family designed for physical AI, autonomous systems, and industrial automation. Available to download today, mimOE Embedded Edition gives OEMs, tier-1 suppliers, system integrators, and agent developers the path to operationalize Agentix-Native systems (aka Agentic AI), in which autonomous agents can reason, coordinate, and act directly on devices, from PoC to scaled operations with certainty.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260723555565/en/

Agentic AI operations are both CPU and GPU bound. Enterprises can now scale with certainty.

Generative AI has centered on the GPU. Agentix-Native systems must spread the work. In a real multi-agent workflow traced by mimik, more than 80 percent of operations were CPU work: discovery, inter-agent collaboration, security, data movement, routing, and lifecycle management. Under 20 percent were model inference on the GPU.

The other major benefit is memory efficiency. mimOE loads shared models once and references them across agents and tenants, so multi-tenant workloads that exceed any current device’s memory under conventional deployment fit comfortably on one X100 Series processor: more agents and more tenants per device, without adding silicon.

mimOE Embedded Edition brings multi-agent choreography, zero-trust security, dynamic service discovery, continued operation through network disruption, and multi-cloud integration as per workflow needs and operator choice, all engine properties rather than custom integration.

The benefits for OEMs and tier-1 suppliers are design wins that reach production instead of stalling at PoC. For system integrators, repeatable delivery across programs. For enterprises, scaled Agentix-Native operations with certainty on compute they already own. For developers, one agentic operating environment from end devices to the cloud.

“The industry has solved intelligence. It has not solved operationalization, and the tools we use in the cloud today do not fit Agentix-Native systems. These are living systems that behave differently by nature; you cannot bolt existing tooling onto them,” said Sam Armani, Senior Vice President of Business Development at mimik. “That is why mimOE and the tools around it are purpose-built for the Agentix era. We run on it ourselves, every day; that is how we move fast and stay flexible as we scale.”

“Agentic AI is shifting compute toward workloads that exercise the CPU, GPU, and NPU together. The AMD Ryzen AI Embedded portfolio was designed for that balance, and with mimik's mimOE running on the platform, our customers can run more agents on the same device and serve more of their own customers per deployment, moving from design-in to production Agentix-Native deployments faster,” said Yousef Khalilollahi, Corporate Vice President and General Manager, AMD.

mimOE Embedded Edition and the Agentix Benchmarking tools are part of mimik’s Agentix-Native toolset. Download the benchmarking tool for the AMD X100 Series processor at (https://www.mimik.com/mimoe-studio-features/benchmark). Choose the type of AI model suited to each workflow and start running Agentix-Native systems today. The three technical studies behind this announcement are here (https://www.mimik.com/agentix-compute-benchmarking). Contact us for a demo or additional questions (https://www.mimik.com/contact-us).

About mimik

mimik is an Agentix-Native company, a pioneer in Device-First Continuum AI and Compute. mimik's software platform is the operating engine for enterprises and developers to scale Agentix-Native systems with certainty, with full flexibility, on their own terms. The company has partnered with major chip vendors, device OEMs, cloud providers, and system integrators, working closely with them to enable fast-track, scaled delivery of AI to organizations in manufacturing, healthcare, transportation, retail, smart buildings, and physical AI more broadly. The outcome is business efficiency across multiple dimensions.

mimOE, Agentix Operating Engine, and Device-First Continuum AI & Compute are trademarks ofmimik Technology Inc. AMD, the AMD arrow logo, Ryzen, and combinations thereof are trademarks of Advanced Micro Devices, Inc. All other trademarks are the property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260723555565/en/

Contacts

mimik Contact:
PR@mimik.com
Arthur Bailey
Tel: +1-206-919-1805

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. Federal Court Permanently Bans 19 Online Sellers of Fake Urolithin A Supplements and Awards $5.3 Million in Damages to Timeline23.7.2026 16:27:00 CEST | Press Release

Timeline (Amazentis SA), the Swiss life-sciences company that pioneered the postbiotic ingredient Urolithin A and its branded form Mitopure®, together with its U.S. subsidiary Timeline Longevity, Inc., announced today that the U.S. District Court for the District of Massachusetts has granted the companies’ motion for default judgments and permanent injunctions against 19 online sellers found to have marketed and sold nutritional supplements falsely advertised as containing Urolithin A. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722951066/en/ Timeline longevity supplement powered by Mitopure; proprietary, highly pure Urolithin A. The order, entered July 15, 2026 by Judge Myong J. Joun in Amazentis SA et al. v. The Partnerships and Unincorporated Associations Identified on Schedule “A”, Case No. 1:25-cv-12913-MJJ (District of Massachusetts), permanently enjoins 19 defaulting defendants from further manufacturing, market

TestMu AI Introduces the Source-to-Verdict Loop in Kane CLI, Carrying Every Requirement to a Ship Decision With Portable Proof23.7.2026 15:45:00 CEST | Press Release

TestMu AI (formerly LambdaTest), the world's first Agentic AI-powered Quality Engineering platform, introduced a source-to-verdict loop in Kane CLI, its natural-language testing tool. Building on Kane CLI's evolution from a browser automation tool, the loop carries a product requirement to a ship decision, writing the tests, running them in the local browser, collecting the proof, measuring coverage from what actually happened, and returning a verdict. As AI agents write, run, and fix tests, a green checkmark is no longer enough: a step that checks nothing passes, a test written against a spec that changed weeks ago passes, and an agent that says “done” without the click ever landing passes. Empty green and earned green are the same color on every dashboard, the number climbs while the risk does not move. Kane CLI closes that gap: it carries a requirement to a verdict, and proves every step of it. One loop. Source to verdict. You no longer hand Kane CLI a test script, you hand it your

Norway’s health system adopts Wolters Kluwer UpToDate Enterprise Edition23.7.2026 15:30:00 CEST | Press Release

Wolters Kluwer Health announced that Norway’s health system has renewed its adoption of UpToDate Enterprise Edition, a market-leading Clinical Decision Support (CDS) solution, for its nationwide health system which includes over 50 public hospitals and 11,000 beds in over 20 trusts. This extends a 15 year partnership with Helsebiblioteket, now part of the Norwegian Institute of Public Health (NIPH). Helping clinicians on a national scale Kjell Tjensvoll, Team Leader for Helsebiblioteket said, ‘‘Providing frontline teams with easy access to the latest medical knowledge is vital in reducing unwarranted variation and improving patient care on a national scale. UpToDate Enterprise Edition enables this, and we are delighted to strengthen our relationship with Wolters Kluwer and provide continued support for clinicians across the country.’’ UpToDate Enterprise Edition was selected by Helsebiblioteket, the Norwegian Electronic Health Library. The selection followed a competitive process by th

Boyd Watterson Global Names John Creswell Global Chief Client Officer to Accelerate Global Growth and Client Engagement23.7.2026 15:00:00 CEST | Press Release

Boyd Watterson Global today announced the appointment of John Creswell as Global Chief Client Officer, a newly created senior leadership role that reflects the firm's continued investment in growth and its evolution into a leading global alternatives investment platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722823117/en/ John Creswell has joined Boyd Watterson Global as Global Chief Client Officer, a newly created role overseeing global sales, client engagement and marketing across the U.S., Europe and APAC. In this role, Creswell will oversee global sales, client engagement and marketing efforts across the United States, Europe and APAC, helping investors access the firm's capabilities while strengthening relationships with institutional and private capital partners worldwide. While based in Chicago, John will spend considerable time at the firm’s headquarters in Cleveland as well as in key offices globally. Cr

Trulioo Launches AI Agent to Resolve Beneficial Ownership Where Global Registries Fall Short23.7.2026 15:00:00 CEST | Press Release

Trulioo, a global risk intelligence platform, today announced the UBO Discovery Agent, the newest layer in Trulioo's UBO Discovery capability inside its business risk and Know Your Business (KYB) verification workflow. AI is reshaping fraud, making it easier for bad actors to hide, and harder for companies to catch them. This makes the already tough job of verifying who actually owns a business even more difficult. Determining a business's ultimate beneficial owner is an ongoing, acute challenge for companies: registry coverage is inconsistent across countries, and even where registries exist, they typically record shareholders and directors of record (rather than the people actually in control). That data isn't simply outdated, it reflects a structural lag: ownership changes and time passes before the filing is made and processed, so a lookup often shows who owned a business months or years ago, not who owns it today. Further, ownership chains that cross borders can break entirely onc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye